2 results
Approved WMOCompleted
Primary objectives: To assess the ability of dabrafenib + trametinib treatment to downsize melanoma tumor masses to enable R0-resection. Secondary objectives: Recurrence free survival; time-to-next treatment, overall survival.
Approved WMOCompleted
The objective of the study is to observe the performance of a new implant during and after surgery. The information from this project will help develop new techniques for using this product and be used to train other surgeons.